Replies to post #94201 on Biotech Values

[apljack]

Aricept and ADAS-COG.

Thanks Idit. I must be recalling a slide at a Pfizer investigators meeting about F/U data tracking the same patients. Masterlongevity has it correct, I think, in that the effect resolved sometime after six months and the declines in both populations (treatment vs. control) paralleled eachother from 6 months on. Pfizer presented the data as ultimately providing the patient with an extra 440 days before their ultimate demise.

aj

[masterlongevity]

There are 3 infusion therapies in Ph 3
gammagard: IV every 2 weeks
Solanezumab: IV every 4 weeks
Bapineuzumab: IV every 13 weeks